Publications:

Glypican-3 is a marker for solid pseudopapillary neoplasm of the pancreas.

Hav M, De Potter A, Ferdinande L, Van Bockstal M, Lem D, Eav S, Pattyn P, Praet M, Cuvelier C, Libbrecht L

Histopathology. 2011 Oct 25.

Colorectal cancer in young Cambodians. 

Monirath Hav, Sokha Eav, Vutha Ky, Claude Cuvelier, Sokneang In, Rithy Kong, Yana Kheang, Chakravuth Oung, Piet Pattyn, Dara Lem. Accepted for publication in Asian Pacific Journal of Cancer Prevention, June 2011.

Anal Incontinence in Nulliparous Patients: clinical, ultrasonographic and manometric characteristics.

V KY, X Barth, F Mion, S Roman, H Damon. Accepted for publication in the journal of Pelvi-péritonéologie, May 2011.

MDM2 gene amplification and protein expressions in colon carcinoma: is targeting MDM2 a new therapeutic option?

Monirath Hav, Louis Libbrecht, Liesbeth Ferdinande, Stephanie Laurant, Marc Peeters, Piet Pattyn, Marleen Praet, Patrick Pauwels. Virchows Arch. 2011 Feb;458(2):197-203.

Clear-cell variant of solid-pseudopapillary neoplasm of the pancreas: a case report and review of the literature.

Monirath Hav, Dara Lem, Serey Vattana Chhut, Rithy Kong, Patrick Pauwels, Claude Cuvelier, Pattyn Piet. Malaysian J Pathol 2009; 31(2):137–141.

MDM2 in colon carcinoma: an immunohistochemical and fluorescence in situ hybridization study.

Monirath Hav, Louis Libbrecht, Piet Pattyn, Marc Peeters, Marleen Praet, Patrick Pauwels. Virchows archiv, 455: 201-202 Suppl. 1 AUG 2009.

Abstracts and posters:

1. Expression of Glypican 3 in Solid Pseudopapillary Neoplasm of the Pancreas: A Series of 7 Cases. 

Monirath Hav, Claude Cuvelier, Liesbeth Ferdiannde, Alexandra De Potter, Sokha Eav, Dara Lem, Piet Pattyn, Marleen Praet and Louis Libbrecht. Ghent Pathology Congress 2011 and 6th Joint Meeting of the British Division of International Academy of Pathology and Pathological Society of Great Britain and Ireland, 10-13 May 2011, Ghent, Belgium.

2. Assessment and prognostic value of regression after neoadjuvant therapy in rectal cancer: the role of tumor shrinkage and fragmentation.

Monirath Hav, Claude Cuvelier, Karen Geboes, Stephanie Laurent, Wim Ceelen, Tom Boterberg, Piet Pattyn, Louis Libbrecht. 22nd Belgian Week of Gastroenterology; Antwerpen, Belgium, March 2010.

3. Resection of liver metastases after neo-adjuvant treatment with Bevacizumab: the Ghent University Hospital’s experience.

K. Geboes, B. Van Den Bossche, S. Laurent, M. Craninx, B. Claerhout, M. Hanssens, B. Berghmans, B. Van Overberghe, L. Verstraete, O. Varin, F. Berrevoet, X. Rogiers, B. De Hemptinne, C. Cuvelier, H. Monirath, L. Libbrecht, M. Peeters, R. Troisi. 22nd Belgian Week of Gastroenterology; Antwerpen, Belgium, March 2010.

4. Assessment and prognostic value of regression after neoadjuvant therapy in rectal cancer: the role of tumor shrinkage and fragmentation.

Monirath Hav, Claude Cuvelier, Karen Geboes, Stephanie Laurent, Wim Ceelen, Tom Boterberg, Piet Pattyn, Louis Libbrecht. Belgian Pathology Society’s Winter Meeting; Brussels, Belgium, December 2009.

5. MDM2 in colon carcinoma – gene amplification and correlation with protein expressions.

Monirath Hav, Louis Libbrecht, Piet Pattyn, Marc Peeters, Marleen Praet, Patrick Pauwels. 22nd European Congress of Pathology; Florence, Italy, September 2009.

6. MDM2 in colon carcinoma – gene amplification and correlation with protein expressions.

Monirath Hav, Louis Libbrecht, Piet Pattyn, Marc Peeters, Marleen Praet, Patrick Pauwels. 4th International MDM2 workshop; Ghent, Belgium, August 2009.

7. Tumour deposits in colorectal carcinoma.

Monirath Hav. Pathology meeting; Ghent, Belgium, March 2009.

8. Appendiceal mucinous tumours.